References
- Arshady R. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J Control Rel 1990; 14: 111–131
- Chiao CSL, Price JC. Modification of gelatin beadlets for zero order sustained release. Pharm Res 1989; 6: 517–520
- Digenis GA, Thomas BG, Shah VP. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 1994; 83: 915–921
- Esposito E, Cortesi R, Nastruzzi C. Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials 1996; 17: 2009–2020
- Hakata T, Sato H, Watanable Y, Matsymoto M. Effect of formaldehyde on the physiochemical properties of soft gekatin capsule shells. Chem Pharm Bull 1994; 42: 1138–1142
- Hodge JE. The amadori rearrangement. Adv Carbohydrate Chem 1955; 10: 169–205
- Kamath KR, Park K. Biodegradable hydrogels in drug delivery. Adv Drug Del Rev 1993; 11: 59–84
- Lee KC, Lee YJ, Kim WB, Cha CY. Monoclonal antibody-based targeting of methotrexate-loaded microspheres. Int J Pharm 1990; 59: 27–33
- Majors KR, Friedman MB. Animal testing of polymer based system. Polymers for controlled drug delivery, PJ Tarcha. CRC Press Inc., Boca Raton, FL 1991; 231–239
- Nahahoka R, Tabata Y, Ikada Y. Potentially of gelatin microspheres as immunological adjuvant. Vaccine 1994; 13: 653–661
- Nastruzzi C, Esposito E, Cotesi R, Gambari R, Menegatti E. Kinetics of bromocriptine release from microspheres: comparative analysis between different in vitro models. J Microencapsulation 1994b; 11: 565–574
- Nastruzzi C, Pasteseni C, Cortesi R, Esposito E, Gambari R, Menegatti E. Production and in vitro evaluation of gelatin microspheres containing an antitumor tetra-amide. J Microencapsulation 1994a; 11: 249–260
- Pecosky DA, Robinsonn JR. Bioadhesive polymers and drug delivery. Polymers for controlled drug delivery, PJ Tarcha. CRC Press, Boca Raton, FL 1991; 99–125
- Ruys L, Vermeesh J, Schacht E, Goethals E. Polymer drug combinations. VII. Polymethacrylates and modified polysaccharides with potential antiarrhythmic activity. Acta Pharm Technol 1983; 29: 105–112
- Throll JH, Freitas JE, Swanso D. Clinical comparison of cardiac blood pool visualization with 99mTc HAS. J Nucl Med 1976; 19: 796–803